Cancers | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

Cancers

Indexings
scopus ncbi doaj ulakbim sci
Short Name Cancers (Basel)
Abbreviated Name cancers (basel)
ISSN 2072-6694
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (68 total)

2019
Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect).
Vol. 11 , No. 7
401 views DOI Abstract
2019
Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells.
Vol. 11 , No. 10 , pp. 1464-
370 views DOI Abstract
2019
A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.
Vol. 11 , No. 9
354 views DOI Abstract
2019
Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality.
Vol. 11 , No. 9
350 views DOI Abstract
2019
Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer.
Vol. 11 , No. 11
341 views DOI Abstract
2019
17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells.
Vol. 11 , No. 10
335 views DOI Abstract
2019
Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells.
Vol. 11 , No. 12
310 views DOI Abstract
2018
Peroxiredoxin II Regulates Cancer Stem Cells and Stemness-Associated Properties of Cancers
Vol. 10 , No. 9 , pp. 305-
301 views DOI Abstract
2019
RAC1B Suppresses TGF-β-Dependent Chemokinesis and Growth Inhibition through an Autoregulatory Feed-Forward Loop Involving PAR2 and ALK5.
Vol. 11 , No. 8
290 views DOI Abstract
2019
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
Vol. 11 , No. 9
286 views DOI Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0